Rules and Regulations. Notice of meeting

Agency: Office of National Drug Control Policy (ONDCP), Executive Office of the President
Action: Notice of meeting
Citation: FR Doc. 2017-22343

Summary

ONDCP announces the fifth meeting of the President's Commission on Combating Drug Addiction and the Opioid Crisis to advance the Commission's work on drug issues and the opioid crisis per Executive Order 13784. The meeting will consist of personal stories regarding addiction and discussion of and voting on the Commission's Final Report that will be posted on ONDCP's Commission Web site below shortly before the meeting.

Dates

The Commission meeting will be held on Wednesday November 1, 2017 from 1:30 p.m. until approximately 3:30 p.m. (Eastern time).

Supplementary Information

The Commission was established in accordance with E.O. 13784 of March 29, 2017, the Commission's charter, and the provisions of the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C. App. 2, to obtain advice and recommendations for the President regarding drug issues. The Executive Order, charter, and information on the Members of the Commission are available on ONDCP's Web site. The Commission will function solely as an advisory body and will make recommendations regarding policies and practices for combating drug addiction with particular focus on the current opioid crisis in the United States. The date of the Commission's final report has been extended until November 1, 2017. Per E.O. 13784, the Commission shall: a. Identify and describe the existing Federal funding used to combat drug addiction and the opioid crisis; b. Assess the availability and accessibility of drug addiction treatment services and overdose reversal throughout the country and identify areas that are underserved; c. Identify and report on best practices for addiction prevention, including healthcare provider education and evaluation of prescription practices, collaboration between State and Federal officials, and the use and effectiveness of State prescription drug monitoring programs; d. Review the literature evaluating the effectiveness of educational messages for youth and adults with respect to prescription and illicit opioids; e. Identify and evaluate existing Federal programs to prevent and treat drug addiction for their scope and effectiveness, and make recommendations for improving these programs; and; f. Make recommendations to the President for improving the Federal response to drug addiction and the opioid crisis. Dated: October 11, 2017. Michael Passante, Deputy General Counsel, Designated Federal Officer. [FR Doc. 2017-22343 Filed 10-13-17; 8:45 am]